cabozatinib | THE "NEW" PROSTATE CANCER INFOLINK

Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of

Prostate Cancer International.
Awards
Other PCI web sites

El Cáncer de Próstata Latinoamérica
Prostate Cancer Africa
Prostate Cancer Caribbean
Solidarité Prostate InfoLink
Copyright © 2008-18 Prostate Cancer International, Inc.

Tasquinimod, ipilimumab, and cabozatinib (XL184): an update

Posted on February 18, 2011 by Sitemaster

At the Genitourinary Cancers Symposium yesterday afternoon, new data were presented from Phase II studies of tasquinimod and cabozatinib (XL184) … READ MORE …

Filed under: Drugs in development, Management | Tagged: cabozatinib, ipilimumab, tasquinimod, XL184 | 1 Comment »

THE "NEW" PROSTATE CANCER INFOLINK

A service of

Awards

Other PCI web sites

Tasquinimod, ipilimumab, and cabozatinib (XL184): an update

Disclaimer

Hot Posts …

… and Archives